- AU$23.41m
- AU$18.67m
- AU$11.34m
- 10
- 53
- 72
- 42
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.75 | ||
| Price to Tang. Book | 2.59 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.48 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -41.17% | ||
| Return on Equity | -47.74% | ||
| Operating Margin | -35.79% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 17.76 | 10.9 | 9.72 | 8.79 | 11.34 | 22.81 | 25.42 | 3.61% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Nuchev Limited is an Australia-based nutritional and wellness business solutions company. The Company is engaged in the development, sales, and marketing of vitamins and dietary supplements. The Company’s products include those branded under Oli6, Bio Practica, and Medicine Tree and a number of globally recognized European brands sold under exclusive license in Australia and New Zealand by bWellness. The Company's primary products include its Oli6 branded goat infant formula and nutritional range, which are sold across Australian Pharmacy and Grocery channels, China and other overseas markets, online through the China Cross-Border e-commerce (CBEC), and general trade retail channels.
Directors
- Justin Breheny CHM
- Ben Dingle CEO
- Chantelle Pritchard CFO
- Owens Chan NED
- Selina Lightfoot NED
- Jeff Martin NED
- Michelle Terry NED
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- April 9th, 2013
- Public Since
- December 9th, 2019
- No. of Shareholders
- 907
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
Australian Stock Exchange - SEATS- Shares in Issue
- 146,339,303
- Address
- Level 12, 636 St Kilda Road,, Melbourne, 3004
- Web
- https://nuchev.com.au/
- Phone
- +61 395448910
- Auditors
- Ernst & Young
Upcoming Events for NUC
Nuchev Ltd Annual Shareholders Meeting
Similar to NUC
A2 Milk
Australian Stock Exchange - SEATS
Australian Agricultural
Australian Stock Exchange - SEATS
Australian Agricultural Projects
Australian Stock Exchange - SEATS
Australian Dairy Nutritionals
Australian Stock Exchange - SEATS
Bega Cheese
Australian Stock Exchange - SEATS
FAQ
What is the Nuchev share price?
As of Today at 22:22 UTC, shares in Nuchev are trading at AU$0.16. This share price information is delayed by 15 minutes.
How has the Nuchev share price performed this year?
Shares in Nuchev last closed at AU$0.16 and the price had moved by -11.11% over the past 365 days. In terms of relative price strength the Nuchev share price has underperformed the ASX All Ordinaries Index by -22% over the past year.
What are the analyst and broker recommendations for Nuchev?
The overall consensus recommendation for Nuchev is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Nuchev dividend yield?
Nuchev does not currently pay a dividend.
Does Nuchev pay a dividend?
Nuchev does not currently pay a dividend.
When does Nuchev next pay dividends?
Nuchev does not currently pay a dividend.
How do I buy Nuchev shares?
To buy shares in Nuchev you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Nuchev?
As of the previous close price of AU$0.16, shares in Nuchev had a market capitalisation of AU$23.41m.
Where are Nuchev shares listed?
Here are the trading details for Nuchev:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: NUC
What kind of share is Nuchev?
Based on an overall assessment of its quality, value and momentum Nuchev is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Nuchev share price forecast for 2025?
The analyst consensus target price for shares in Nuchev is AU$0.14. That is 12.5% below the last closing price of AU$0.16.
Analysts covering Nuchev currently have a consensus Earnings Per Share (EPS) forecast of -AU$0.01 for the next financial year.
Find out moreWhat is the trend in the Nuchev share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Nuchev. Over the past six months, its share price has outperformed the ASX All Ordinaries Index by +27.54%.
As of the last closing price of AU$0.16, shares in Nuchev were trading -3.74% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Nuchev PE Ratio?
The Nuchev PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.16.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Nuchev?
Nuchev's management team is headed by:
- Justin Breheny - CHM
- Ben Dingle - CEO
- Chantelle Pritchard - CFO
- Owens Chan - NED
- Selina Lightfoot - NED
- Jeff Martin - NED
- Michelle Terry - NED